ImmunoGen surges after cancer drug study hits a 'home run'

Österreich Nachrichten Nachrichten

ImmunoGen surges after cancer drug study hits a 'home run'
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 Reuters
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 97%

ImmunoGen Inc shares more than doubled on Wednesday after the company said its experimental ovarian cancer drug helped extend the lives of patients in a late-stage trial.

shares more than doubled on Wednesday after the company said its experimental ovarian cancer drug helped extend the lives of patients in a late-stage trial.

The biotech company said the drug candidate, Elahere, also significantly prolonged the time that a patient lives without the cancer worsening, when compared with chemotherapy. The U.S. FDA had earlier given accelerated approval for Elahere, based on data from a single-arm trial in patients who had received at least one prior line of therapy that includes Swiss-based Roche Holding AG'sThe data was a "home run" for ImmunoGen and should remove any doubts that Elahere will get confirmatory approval by the FDA, Truist Securities analyst Asthika Goonewardene said in note to clients.

The company said it plans to submit a marketing application in Europe and a supplemental application in the U.S. for the conversion to a regular approval by the second half of the year. Shares of the drug developer jumped to a a near five-year high of $11.95 on Wednesday, adding roughly $1.75 billion to its market capitalization.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Reuters /  🏆 2. in US

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Immunogen stock more than doubles on heavy volume after positive trial data ovarian cancer treatmentImmunogen stock more than doubles on heavy volume after positive trial data ovarian cancer treatmentShares of Immunogen Inc. blasted 121.2% higher on heavy volume toward a five-year high in premarket trading Wednesday, after the biopharmaceutical company...
Weiterlesen »

Uber Technologies Inc Stock Price Today | NYSE UBER Live Ticker - Investing.comUber Technologies Inc Stock Price Today | NYSE UBER Live Ticker - Investing.comView today's Uber Technologies Inc stock price and latest UBER news and analysis. Create real-time notifications to follow any changes in the live stock price.
Weiterlesen »

Disinformation Inc: House GOP steps up 'censorship' inquiry into Blinken's State DepartmentDisinformation Inc: House GOP steps up 'censorship' inquiry into Blinken's State DepartmentEXCLUSIVE — House Republicans are expanding the scope of their investigation into the Biden administration's alleged ties to 'censorship' and 'disinformation' tracking through a new demand for a trove of records from the State Department.
Weiterlesen »

Olive Garden parent Darden to acquire Ruth’s Chris Steak owner for $715 million in cashOlive Garden parent Darden to acquire Ruth’s Chris Steak owner for $715 million in cashOlive Garden parent Darden Restaurants Inc. said Wednesday it’s acquiring Ruth’s Hospitality Group Inc. owner of Ruth’s Chris Steak House, in an all-cash...
Weiterlesen »

Immigration activists battle to stop Wednesday deportation of South Philly manImmigration activists battle to stop Wednesday deportation of South Philly manHis two young daughters think he has gone to help a friend. 'This is a perfect example of our immigration system running amok,' said Andy Kang, head of the PA Immigration and Citizenship Coalition.
Weiterlesen »

Jenna Ortega Puts a ‘Wednesday’ Twist On The Met Gala ThemeJenna Ortega Puts a ‘Wednesday’ Twist On The Met Gala ThemeJenna Ortega wore a preppy, edgy, Thom Browne ensemble to the 2023 Met Gala
Weiterlesen »



Render Time: 2025-03-13 23:03:23